Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,014 | 246 | 98.7% |
| Education | $53.88 | 3 | 1.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $0.95 | 2 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $820.03 | 74 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $409.53 | 25 | $0 (2023) |
| Actelion Pharmaceuticals US, Inc. | $291.82 | 16 | $0 (2023) |
| United Therapeutics Corporation | $282.92 | 8 | $0 (2024) |
| Grifols USA, LLC | $247.47 | 16 | $0 (2024) |
| Genentech USA, Inc. | $242.01 | 14 | $0 (2022) |
| Sunovion Pharmaceuticals Inc. | $172.57 | 13 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $170.66 | 9 | $0 (2024) |
| Merck Sharp & Dohme LLC | $161.87 | 8 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $133.97 | 8 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $169.19 | 8 | Merck Sharp & Dohme LLC ($92.67) |
| 2023 | $580.06 | 27 | Actelion Pharmaceuticals US, Inc. ($60.23) |
| 2022 | $277.52 | 16 | Novartis Pharmaceuticals Corporation ($51.35) |
| 2021 | $283.32 | 16 | Boehringer Ingelheim Pharmaceuticals, Inc. ($67.60) |
| 2020 | $375.47 | 26 | GlaxoSmithKline, LLC. ($148.08) |
| 2019 | $771.75 | 51 | GlaxoSmithKline, LLC. ($146.02) |
| 2018 | $726.70 | 50 | GlaxoSmithKline, LLC. ($161.74) |
| 2017 | $884.79 | 57 | United Therapeutics Corporation ($223.06) |
All Payment Transactions
251 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/15/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $20.42 | General |
| Category: Respiratory | ||||||
| 05/15/2024 | Merck Sharp & Dohme LLC | ZERBAXA (Drug), RECARBRIO | Food and Beverage | In-kind items and services | $18.64 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 04/24/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Food and Beverage | In-kind items and services | $26.72 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/23/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $15.06 | General |
| Category: Pulmonology | ||||||
| 03/15/2024 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $28.01 | General |
| 03/06/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug), RECARBRIO, ZERBAXA | Food and Beverage | In-kind items and services | $19.30 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 02/08/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $25.02 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 01/23/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $16.02 | General |
| 12/06/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $12.75 | General |
| Category: Respiratory | ||||||
| 12/04/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.11 | General |
| Category: Immunology | ||||||
| 11/21/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $28.75 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2023 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $15.79 | General |
| Category: Respiratory | ||||||
| 11/17/2023 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $23.84 | General |
| Category: Inflammation | ||||||
| 11/16/2023 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $14.50 | General |
| Category: Pulmonology | ||||||
| 11/15/2023 | Jazz Pharmaceuticals Inc. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $34.72 | General |
| Category: NEUROLOGY | ||||||
| 10/25/2023 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $18.72 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 10/25/2023 | Novartis Pharmaceuticals Corporation | XOLAIR (Drug) | Food and Beverage | In-kind items and services | $18.24 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 10/17/2023 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $28.83 | General |
| Category: Cardiology | ||||||
| 10/10/2023 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $21.39 | General |
| Category: Respiratory | ||||||
| 10/09/2023 | Insmed, Inc. | Arikayce (Drug) | Education | In-kind items and services | $16.24 | General |
| Category: Respiratory | ||||||
| 09/26/2023 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $28.97 | General |
| Category: Respiratory | ||||||
| 09/19/2023 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $25.07 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/18/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $17.45 | General |
| 09/06/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.92 | General |
| Category: Immunology | ||||||
| 09/01/2023 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $34.49 | General |
| Category: Inflammation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 377 | 646 | $227,291 | $73,999 |
| 2022 | 7 | 289 | 544 | $190,979 | $61,805 |
| 2021 | 7 | 305 | 575 | $200,638 | $66,933 |
| 2020 | 9 | 392 | 710 | $238,680 | $79,941 |
All Medicare Procedures & Services
33 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 126 | 248 | $127,720 | $39,661 | 31.1% |
| 99292 | Critical care, each additional 30 minutes | Facility | 2023 | 67 | 155 | $39,990 | $12,583 | 31.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 50 | 84 | $21,672 | $7,551 | 34.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 30 | 52 | $11,076 | $4,716 | 42.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 22 | 25 | $7,100 | $3,133 | 44.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 15 | 15 | $6,090 | $2,511 | 41.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 16 | 16 | $6,928 | $2,115 | 30.5% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 17 | 17 | $2,482 | $708.92 | 28.6% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2023 | 17 | 17 | $1,632 | $545.67 | 33.4% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 17 | 17 | $2,601 | $473.43 | 18.2% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 108 | 224 | $115,360 | $36,879 | 32.0% |
| 99292 | Critical care, each additional 30 minutes | Facility | 2022 | 79 | 175 | $45,150 | $14,520 | 32.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 44 | 68 | $17,544 | $6,204 | 35.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 18 | 34 | $7,242 | $2,654 | 36.6% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2022 | 13 | 14 | $2,044 | $628.93 | 30.8% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2022 | 13 | 14 | $1,344 | $470.62 | 35.0% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2022 | 14 | 15 | $2,295 | $448.58 | 19.5% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 113 | 222 | $114,330 | $38,251 | 33.5% |
| 99292 | Critical care delivery critically ill or injured patient | Facility | 2021 | 87 | 205 | $52,890 | $17,732 | 33.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 47 | 66 | $17,028 | $6,137 | 36.0% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 22 | 34 | $7,242 | $2,755 | 38.0% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 14 | 17 | $2,601 | $942.89 | 36.3% |
| 36556 | Insertion of central venous catheter for infusion, patient 5 years or older, not tunneled | Facility | 2021 | 11 | 14 | $5,544 | $929.32 | 16.8% |
| 76937 | Ultrasound guidance for accessing into blood vessel | Facility | 2021 | 11 | 17 | $1,003 | $186.51 | 18.6% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 122 | 247 | $127,205 | $43,523 | 34.2% |
About Dr. Kavan Ramachandran, MD
Dr. Kavan Ramachandran, MD is a Internal Medicine healthcare provider based in Salem, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/19/2007. The National Provider Identifier (NPI) number assigned to this provider is 1972799252.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kavan Ramachandran, MD has received a total of $4,069 in payments from pharmaceutical and medical device companies, with $169.19 received in 2024. These payments were reported across 251 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($4,014).
As a Medicare-enrolled provider, Ramachandran has provided services to 1,363 Medicare beneficiaries, totaling 2,475 services with total Medicare billing of $282,678. Data is available for 4 years (2020–2023), covering 33 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Critical Care Medicine, Pulmonary Disease
- Location Salem, OR
- Active Since 09/19/2007
- Last Updated 02/26/2013
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1972799252
Products in Payments
- NUCALA (Biological) $391.22
- ORENITRAM (Drug) $223.06
- Prolastin-C Liquid (Biological) $189.70
- UPTRAVI (Drug) $184.26
- Xolair (Biological) $163.41
- BREO (Drug) $160.91
- SYMBICORT (Drug) $152.97
- TRELEGY ELLIPTA (Drug) $137.05
- DUPIXENT (Biological) $134.76
- LONHALA MAGNAIR (Drug) $122.86
- ANORO (Drug) $121.11
- XOLAIR (Biological) $115.73
- BREZTRI (Drug) $98.71
- FLEX. INTUBATION VIDEO SCOPE 5.5 X 65 CM (Device) $97.30
- FASENRA (Drug) $93.85
- Esbriet (Biological) $78.60
- GLASSIA (Biological) $77.98
- Arikayce (Drug) $73.84
- TYVASO (Drug) $59.86
- TEZSPIRE (Biological) $58.33
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Salem
Dr. Michael Katcher, Md, MD
Internal Medicine — Payments: $124,347
Jonh Pineda-Bonilla, Md, MD
Internal Medicine — Payments: $51,042
Dr. Garry Miller, D.o, D.O
Internal Medicine — Payments: $17,070
David Bennion, Md, MD
Internal Medicine — Payments: $13,939
Mr. Gautam Jha, Md, MD
Internal Medicine — Payments: $11,191
Dr. Troy Lunceford, Md, MD
Internal Medicine — Payments: $10,868